Filana Therapeutics (FLNA) Return on Sales [ROS] (2010 - 2026)
Filana Therapeutics (FLNA) recorded Return on Sales [ROS] of 93.36% in Q4 2013, up 167.91 percentage points from -74.55% a year earlier and up 132.99 percentage points from the prior quarter.
Powered by 
Analysis
Filana Therapeutics (FLNA) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
For FY2013, Filana Therapeutics reported Return on Sales [ROS] of 76.28%, up 112.06 percentage points from FY2012.
- Annual Return on Sales [ROS] has a four-year change of +109.12 percentage points (FY2009 to FY2013).
- Across earlier years, Return on Sales [ROS] came in at -35.79% in FY2012 (-5.19 pp), -30.60% in FY2011 (+50.92 pp), -81.52% in FY2010 (-48.68 pp) and -32.85% in FY2009.
- The Q4 2013 figure is the highest quarterly Return on Sales [ROS] in data going back to Q2 2010.
- On a year-over-year basis, Return on Sales [ROS] rose in four of the last eight quarters, with an average year-over-year change of +17.50 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 167.91 percentage points in Q4 2013, against a drop of 53.29 percentage points in Q4 2012 at the low end.
- Per Business Quant, the preceding three quarters came in at -39.63% (Q3 2013), -16.28% (Q2 2013) and -22.63% (Q1 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,139.85 Bn | 1,108.44 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 634.68 Bn | 554.54 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 500.89 Bn | 474.00 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 354.57 Bn | 308.95 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 300.14 Bn | 264.13 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 263.08 Bn | 236.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.91 Bn | 193.31 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.96 Bn | 168.15 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.07 Bn | 116.71 Bn | 10.94 Bn | 28.37% |
| 10 | Filana Therapeutics | 30.85 Mn | -339.99 Mn | - | -1,257.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,257.43% |
| Mar 31, 2026 | -1,415.46% |
| Dec 31, 2025 | -1,391.38% |
| Sep 30, 2025 | -1,016.28% |
| Jun 30, 2025 | -3,739.04% |
| Mar 31, 2025 | -1,943.56% |
| Dec 31, 2024 | -1,638.17% |
| Sep 30, 2024 | -1,169.71% |
| Jun 30, 2024 | -2,651.21% |
| Mar 31, 2024 | -1,122.41% |
| Dec 31, 2023 | -1,443.26% |
| Sep 30, 2023 | -1,390.47% |
| Jun 30, 2023 | -1,309.24% |
| Mar 31, 2023 | -1,292.64% |
| Dec 31, 2022 | -1,347.30% |
| Sep 30, 2022 | -2,431.09% |
| Dec 31, 2013 | 93.36% |
| Sep 30, 2013 | -39.63% |
| Jun 30, 2013 | -16.28% |
| Mar 31, 2013 | -22.63% |
API Access
Filana Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=FLNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "FLNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=FLNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();